Valuation: Procter & Gamble Health Limited

Market Cap 89.73B 935M 822M 778M 705M 1.33B 1.33B 9.3B 3.59B 45.79B 3.51B 3.43B 147B P/E 2027 *
24.4x
P/E 2028 * 22x
Enterprise Value 89.73B 935M 822M 778M 705M 1.33B 1.33B 9.3B 3.59B 45.79B 3.51B 3.43B 147B EV / Sales 2027 *
5.8x
EV / Sales 2028 * 5.15x
Free-Float
47.81%
Yield 2027 *
2.01%
Yield 2028 * 2.18%
1 day-0.12%
1 week-1.89%
Current month-6.39%
1 month-5.64%
3 months-13.37%
6 months+11.16%
Current year-5.32%
1 week 5,300
Extreme 5300
5,544.5
1 month 5,300
Extreme 5300
5,825
Current year 4,707
Extreme 4707
6,975
1 year 4,707
Extreme 4707
6,975
3 years 4,636.55
Extreme 4636.55
6,975
5 years 3,870.1
Extreme 3870.1
6,975
10 years 686
Extreme 686
7,500
Manager TitleAgeSince
Chief Executive Officer 57 01/04/2018
Director of Finance/CFO - 01/10/2025
Chief Tech/Sci/R&D Officer - 01/09/2025
Director TitleAgeSince
Director/Board Member 57 01/04/2018
Director/Board Member 51 01/06/2019
Chairman 69 01/04/2025
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-1.89% - - 938M
-0.77%+0.04%+15.84%+61.24% 46.37B
-0.72%-0.36%+42.69%+104.39% 37.26B
+0.92%+4.74%+24.62%+100.78% 12.53B
-1.14%-0.77%-7.72%+17.21% 11.8B
+0.19%+0.19%+17.87%+140.09% 8.97B
-1.33%+0.86%+39.84%-15.35% 7.29B
-0.64%-3.35%+26.92%+37.17% 7.09B
-2.28%-4.97%+17.95%+199.55% 7.01B
-1.19%-1.78%-50.77%+1.98% 4.99B
Average -0.71%-0.27%+14.14%+71.89% 15.92B
Weighted average by Cap. -0.69%+0.41%+21.33%+76.84%

Financials

2027 *2028 *
Net sales 15.47B 161M 142M 134M 122M 229M 230M 1.6B 619M 7.9B 605M 592M 25.39B 17.43B 182M 160M 151M 137M 258M 259M 1.81B 697M 8.9B 682M 667M 28.6B
Net income 3.67B 38.26M 33.63M 31.82M 28.87M 54.23M 54.51M 381M 147M 1.87B 144M 141M 6.02B 4.09B 42.59M 37.44M 35.43M 32.13M 60.36M 60.68M 424M 164M 2.09B 160M 156M 6.7B
Net Debt - -
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,276
Date Price Change Volume
28/09/26 ₹5,399.50 -0.12% 9,829
25/09/26 ₹5,406.00 -0.19% 3,567
24/09/26 ₹5,416.50 -0.65% 7,525
23/09/26 ₹5,452.00 -0.13% 17,583
22/09/26 ₹5,459.00 -0.81% 5,659
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Annual profits - Rate of surprise